Y200-6691 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-4-ethoxybenzamide

Y200-6691 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-4-ethoxybenzamide
Y200-6691 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-4-ethoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-6691
N-(1H-1,3-benzodiazol-2-yl)-4-ethoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-6691

Molecular Formula

C16H15N3O2 (C16 H15 N3 O2)

Compound Name

N-(1H-1,3-benzodiazol-2-yl)-4-ethoxybenzamide

IUPAC name

N-(1H-13-benzodiazol-2-yl)-4-ethoxybenzamide

SMILES

CCOc(cc1)ccc1C(Nc1nc(cccc2)c2[nH]1)=O

InChI

InChI=1S/C16H15N3O2/c1-2-21-12-9-7-11(8-10-12)15(20)19-16-17-13-5-3-4-6-14(13)18-16/h3-10H,2H2,1H3,(H2,17,18,19,20)

InChI Key

YFEFQGWUNNIIQV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02718468

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

281.31

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

2.720

Distribution Coefficient, logD

2.719

Water Solubility, LogSw

-3.10

Polar Surface Area

50.878

Acid Dissociation Constant (pKa)

10.30

Base Dissociation Constant (pKb)

3.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.50

Y200-6691 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with Y200-6691 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-6691?
Check Price and Availability of Y200-6691, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-6691 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-6691
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-6691
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-6691 available by request